Edition:
United States

BioLife Solutions Inc (BLFS.OQ)

BLFS.OQ on NASDAQ Stock Exchange Capital Market

12.61USD
22 Jun 2018
Change (% chg)

-- (--)
Prev Close
$12.61
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
32,806
52-wk High
$13.94
52-wk Low
$2.33

Chart for

About

BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management... (more)

Overall

Beta: 0.41
Market Cap(Mil.): $190.47
Shares Outstanding(Mil.): 15.10
Dividend: --
Yield (%): --

Financials

  BLFS.OQ Industry Sector
P/E (TTM): -- 29.56 34.14
EPS (TTM): -0.15 -- --
ROI: -17.75 13.56 13.10
ROE: -29.53 15.35 15.09

BRIEF-Biolife Solutions Announces Partial Redemption Of Series A Preferred Stock

* BIOLIFE SOLUTIONS ANNOUNCES PARTIAL REDEMPTION OF SERIES A PREFERRED STOCK Source text for Eikon: Further company coverage:

May 17 2018

BRIEF-BioLife Solutions Reports Q1 Loss Per Share $0.01

* BIOLIFE SOLUTIONS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

May 10 2018

BRIEF-Casdin Capital To Become Shareholder In Biolife Solutions

* CASDIN CAPITAL LLC, ENTERED INTO AN AGREEMENT TO PURCHASE 1,000,000 BIOLIFE SOLUTIONS SHARES IN PRIVATE DEAL Source text for Eikon: Further company coverage:

Apr 09 2018

BRIEF-BioLife Solutions Announces Preliminary Q1 Revenue Of $3.8 Mln, Up 61 Pct

* FOR 2018 BIOPRESERVATION MEDIA REVENUE EXPECTED TO RANGE BETWEEN $14.5 MILLION TO $15.5 MILLION

Apr 02 2018

BRIEF-BioLife Solutions Q4 Loss Per Share $0.05

* BIOLIFE SOLUTIONS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Mar 08 2018

BRIEF-Biolife Solutions Executes OEM Agreement With MilliporeSigma

* BIOLIFE SOLUTIONS EXECUTES OEM AGREEMENT WITH MILLIPORESIGMA Source text for Eikon: Further company coverage:

Feb 13 2018

BRIEF-Biolife Solutions Says Co And Savsu Technologies Amended Their Arrangement With Respect To JV

* BIOLIFE SOLUTIONS SAYS ON JAN 22 CO AND SAVSU TECHNOLOGIES AMENDED THEIR ARRANGEMENT WITH RESPECT TO THEIR JV, BIOLOGISTEX- SEC FILING

Jan 26 2018

Earnings vs. Estimates